Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

NCT06376916 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Tachycardia Atrial
Atrial Fibrillation
Atrial Flutter With Rapid Ventricular Response

Interventions

DRUG: Magnesium Sulfate 2 G
DRUG: Magnesium Sulfate 4 G
DRUG: Saline

Sponsor

Wake Forest University Health Sciences